Biosensors market in North America to hold the highest market share during the forecast period
The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026.
Statistical methods called biosensors are able to identify biological molecules and transform them into quantifiable signals. Due to the rising need for quick, precise, and affordable diagnostic instruments in healthcare, environmental monitoring, food safety, and other applications, the biosensors market has been expanding quickly in recent years. In this article, we'll examine the current situation of the biosensors market, the reasons promoting its expansion, and the sector's outlook.
Application Areas:
Applications for food, environmental, and medical biosensors can be broadly categorised. Biosensors are utilised in the medical field for disease diagnosis, medication discovery, and the monitoring of biomarkers like cholesterol, glucose, and others. Biosensors are utilised in the environmental industry to find pollutants and keep track of water quality. Biosensors are used in the food industry to find allergies, poisons, and infections in food products.
Inquiry Before Buying @
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=798
Technology Trends:
The demand for more sensitive, accurate, and adaptable biosensors is driving a rapid evolution of the biosensors industry and the emergence of new technologies. Miniaturization, integration with smartphones and other mobile devices, and the use of nanomaterials and bioreceptors for improved performance are some of the major technological advancements in this market.
Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Cytiva (UK), Dexcom, Inc. (US), Lifescan IP Holdings, LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), ACON Laboratories, Inc. (US), CARDEA BIO INC., (US), Conductive Technologies (US), EarlySense (Israel), Innovative Sensor Technology IST AG (Switzerland), LifeSignals (US), NeuroSky (US), Pinnacle Technology Inc. (US), SD Biosensor, INC. (South Korea), VitalConnect (US), and Xsensio (Switzerland) are a few of the key players in the biosensors market.
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
No comments: